Irving Investors Investor

Irving Investors focuses on disruptive technology and high growth opportunities.
Technology: Cell_Therapies
Industry: Finance, Financial Services, Venture Capital
Headquarters: New York, New York, United States
Founded Date: 2009-01-01
Employees Number: 1-10
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Late Stage Venture, Seed
Number Of Exits: 15
Acquisitions Number: 15
Estimated Revenue: $1M to $10M

Visit Website
info@irvinginvestors.com
Register and Claim Ownership